Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05262907 · ClinicalTrials.gov registry record · NA

Ventripoint Single Ventricle Study

A NA study of Congenital Heart Disease and Single-ventricle, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05262907 is a NA study of Congenital Heart Disease and Single-ventricle that is actively recruiting participants, run by Duke University. The registered enrollment target is 100 participants, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05262907, a NA study of Congenital Heart Disease and Single-ventricle, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

Interventions

  • DEVICE Transthoracic Echocardiogram or Cardiac MRI
  • DEVICE Ventripoint Echocardiogram

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-07-08
Est. Completion 2027-08
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05262907

The ClinicalTrials.gov registry entry for NCT05262907 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (79% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which Transthoracic Echocardiogram or Cardiac MRI is the first listed.

NCT05262907 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05262907 about?

NCT05262907 is a clinical study titled "Ventripoint Single Ventricle Study". This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

What is the current status of trial NCT05262907?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-07-08. Estimated completion is 2027-08.

What conditions does trial NCT05262907 study?

This clinical trial studies the following conditions: Congenital Heart Disease, Single-ventricle.

What interventions are being tested in trial NCT05262907?

The interventions under investigation include: Transthoracic Echocardiogram or Cardiac MRI (DEVICE), Ventripoint Echocardiogram (DEVICE).

Who is sponsoring clinical trial NCT05262907?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05262907 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.